Atlas Trials

The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

Clinical trial NCT07668076 · COMPLETED

Trial details

NCT number
NCT07668076
Sponsor
Damanhour University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerDoxorubicin Induced Cardiomyopathy
Start date
2022-11-15
Primary completion
2024-10-20
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.